Received: 28 August 2018
Accepted: 10 December 2018
First Online: 17 December 2018
Ethics approval and consent to participate
: Not applicable.
: Written informed consent was obtained from the patient for the publication of this case report. A copy of the written consent is available for review by the editor of this journal.
: M.I. received departmental scholarship funds of ≥1,000,000 yen per year for direct expenses from MSD K.K., Bristol-Myers Squibb, BIOTORONIK JAPAN, Inc., Astellas Pharma Inc., Shionogi & Co., Ltd., and Otsuka Pharmaceutical Co., Ltd., in 2015, MSD K.K., Astellas Pharma Inc., Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., and Otsuka Pharmaceutical Co., Ltd., in 2016, and MSD K.K., Shionogi & Co., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Ltd., and Daiichi Sankyo Company, Ltd., in 2017. The companies associated with this funding were not involved in the manuscript preparation or the decision to publish the present case report. All other authors have no competing interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.